Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GGPS1 | O95749 | 7/20 | 0.68 |
| ▸ | FDPS | P14324 | 11/20 | 0.65 |
| ▸ | SMPD1 | P17405 | 5/20 | 0.63 |
| ▸ | LPAR3 | Q9UBY5 | 3/20 | 0.63 |
| ▸ | LPAR1 | Q92633 | 1/20 | 0.63 |
| ▸ | LPAR2 | Q9HBW0 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6896475 | 1.00 | GGPS1 (0.68) | GGPS1FDPSSMPD1LPAR3LPAR1 | |
| SCHEMBL21101802 | 1.00 | GGPS1 (0.68) | GGPS1FDPSSMPD1LPAR3LPAR1 | |
| SCHEMBL11406652 | 1.00 | GGPS1 (0.68) | GGPS1FDPSSMPD1LPAR3LPAR1 | |
| SCHEMBL8978238 | 0.98 | GGPS1 (0.65) | GGPS1FDPSSMPD1LPAR3LPAR1 | |
| SCHEMBL8672279 | 0.98 | FDPS (0.64) | GGPS1FDPSSMPD1LPAR3LPAR1 | |
| SCHEMBL29085255 | 0.96 | GGPS1 (0.63) | GGPS1FDPSSMPD1LPAR3LPAR1 | |
| SCHEMBL29085266 | 0.96 | GGPS1 (0.63) | GGPS1FDPSSMPD1LPAR3LPAR1 | |
| SCHEMBL3861125 | 0.95 | FDPS (0.61) | GGPS1FDPSSMPD1LPAR3LPAR1 | |
| SCHEMBL3295661 | 0.95 | FDPS (0.61) | GGPS1FDPSSMPD1LPAR3LPAR1 | |
| SCHEMBL21879326 | 0.91 | GGPS1 (0.63) | GGPS1FDPSSMPD1LPAR3LPAR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 26 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-4012480-A | MULTISTAGE | COMMISSARIAT A L'ENERGIE ATOMIQUE (FR) | 1977-03-15 | — | — | US | claimed |
| EP-1299395-B1 | OXAZINOQUINOLONES USEFUL FOR THE TREATMENT OF VIRAL INFECTIONS | UPJOHN CO (US) | 2004-09-15 | — | — | EP | disclosed |
| EP-1169744-B1 | WET-ON-WET COATING METHOD FOR PRODUCING COMPOSITE BODIES THAT ARE SUITABLE FOR USE IN LITHIUM ION BATTERIES | BASF AG (DE) | 2004-06-30 | — | — | EP | disclosed |
| US-6673793-B2 | N-(4-CHLOROBENZYL)-9-(MORPHOLIN-4-YLMETHYL)-7-OXO-2-(S)-PYRIDIN-2-YL-2,3-DIHYDRO-7H-(1,4) OXAZINO(2,3,4-IJ)QUINOLINE-6-CARBOXAMIDE, FOR EXAMPLE; INHIBITING A VIRAL DNA POLYMERASE; TREATING VIRUSES OF HERPES FAMILY | PHARMACIA & UPJOHN CO. | 2004-01-06 | — | — | US | disclosed |
| EP-1088007-B1 | COMPOSITIONS SUITABLE FOR ELECTROCHEMICAL CELLS | BASF AG (DE) | 2003-02-26 | — | — | EP | disclosed |
| EP-0970529-B1 | METHOD FOR PRODUCING SHAPED BODIES FOR LITHIUM ION BATTERIES | BASF AG (DE) | 2002-08-28 | — | — | EP | disclosed |
| US-20020103170-A1 | Oxazinoquinolones useful for the treatment of viral infections | PHARMACIA & UPJOHN COMPANY | 2002-08-01 | — | — | US | disclosed |
| EP-0890196-B1 | MIXTURES SUITABLE AS SOLID ELECTROLYTES OR SEPARATORS FOR ELECTROCHEMICAL CELLS | BASF AG (DE) | 2002-06-12 | — | — | EP | disclosed |
| EP-1211552-A2 | Mixtures suitable for electrochromic windows | BASF AKTIENGESELLSCHAFT (DE) | 2002-06-05 | — | — | EP | disclosed |
| EP-1209755-A2 | Mixtures suitable as solid electrolyte or separator for electrochemical cells | BASF AKTIENGESELLSCHAFT (DE) | 2002-05-29 | — | — | EP | disclosed |
| WO-2000062362-A1 | WET-ON-WET COATING METHOD FOR PRODUCING COMPOSITE BODIES THAT ARE SUITABLE FOR USE IN LITHIUM ION BATTERIES | BASF AKTIENGESELLSCHAFT (DE) | 2000-10-19 | — | — | WO | disclosed |
| EP-1023746-A1 | MIXTURES WITH SPECIAL SOFTENING AGENTS SUITED AS A SOLID ELECTROLYTE OR SEPARATOR FOR ELECTROCHEMICAL CELLS | BASF AKTIENGESELLSCHAFT (DE) | 2000-08-02 | — | — | EP | disclosed |
| WO-2000008068-A1 | COMPOSITIONS SUITABLE FOR ELECTROCHEMICAL CELLS | BASF AKTIENGESELLSCHAFT (DE) | 2000-02-17 | — | — | WO | disclosed |
| WO-1999057161-A1 | COMPOSITIONS SUITABLE FOR ELECTROCHEMICAL CELLS | BASF AKTIENGESELLSCHAFT (DE) | 1999-11-11 | — | — | WO | disclosed |
| WO-1999019921-A1 | MIXTURES WITH Li-CONTAINING SOLIDS SUITABLE AS SOLID ELECTROLYTES OR SEPARATORS FOR ELECTROCHEMICAL CELLS | BASF AKTIENGESELLSCHAFT (DE) | 1999-04-22 | — | — | WO | disclosed |
| WO-1999018621-A1 | MIXTURES WITH SPECIAL SOFTENING AGENTS SUITED AS A SOLID ELECTROLYTE OR SEPARATOR FOR ELECTROCHEMICAL CELLS | BASF AKTIENGESELLSCHAFT (DE) | 1999-04-15 | — | — | WO | disclosed |
| EP-0890196-A1 | MIXTURES SUITABLE AS SOLID ELECTROLYTES OR SEPARATORS FOR ELECTROCHEMICAL CELLS | BASF AKTIENGESELLSCHAFT (DE) | 1999-01-13 | — | — | EP | disclosed |
| WO-1997037397-A1 | MIXTURES SUITABLE AS SOLID ELECTROLYTES OR SEPARATORS FOR ELECTROCHEMICAL CELLS | BASF AKTIENGESELLSCHAFT (DE) | 1997-10-09 | — | — | WO | disclosed |
| US-4237100-A | Isotopic enrichment of uranium with respect to an isotope | COMMISSARIAT A L'ENERGIE ATOMIQUE (FR) | 1980-12-02 | — | — | US | disclosed |
| US-4012480-A | MULTISTAGE | COMMISSARIAT A L'ENERGIE ATOMIQUE (FR) | 1977-03-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020103170-A1 | Oxazinoquinolones useful for the treatment of viral infections | ZC3HAV1, RPL5, ZC3HAV1L | GGPS1 312/4885FDPS 291/4885SMPD1 1352/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.